Physician profile
Benjamin K Yang
NPI 1548429228
$4,120.79
in general payments reported to CMS, 2019-2025
25 companies · $652 in 2025
The $652 reported for 2025 was more than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $225 · 2020: $238 · 2021: $632 · 2022: $348 · 2023: $1,087 · 2024: $939 · 2025: $652.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,678.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,677.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $522.45 | 2021-2025 | Symplicity G3, Onyx Frontier |
| Inari Medical, INC. | $490.27 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Abiomed | $467.50 | 2021-2025 | Impella |
| Abbott Laboratories | $463.08 | 2019-2023 | Jot Dx |
| Novartis Pharmaceuticals Corporation | $390.47 | 2019-2025 | |
| Pfizer INC. | $303.53 | 2020-2025 | |
| Amgen INC. | $282.03 | 2019-2025 | Repatha, Repatha |
| E.R. Squibb & Sons, L.L.C. | $274.09 | 2019-2025 | Camzyos, Eliquis |
| Corcym INC | $158.69 | 2023 | Perceval |
| Ge Healthcare | $156.38 | 2024 | |
| Baxter Healthcare | $133.04 | 2020 | |
| Sanofi-Aventis U.S. LLC | $93.25 | 2021-2023 | |
| Janssen Pharmaceuticals, INC | $62.97 | 2019-2022 | |
| Boston Scientific Corporation | $58.36 | 2019-2023 | Varithena Administration Pack |
| Merck Sharp & Dohme LLC | $42.18 | 2023 | Verquvo |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Philips North America LLC | $32.72 | 2022 | |
| Shockwave Medical, INC | $31.06 | 2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Recor Medical INC | $24.39 | 2024 | Paradise Renal Denervation System |
| Allergan, INC. | $23.59 | 2020 | |
| Cleerly, INC. | $22.15 | 2025 | Cleerly Labs, Cleerly Ischemia |
| Novo Nordisk INC | $21.34 | 2024 | Rybelsus, Ozempic |
| Cvrx, INC. | $20.90 | 2025 | Barostim Neo System |
| Ionis Pharmaceuticals, INC. | $19.84 | 2025 | Tryngolza |
| Medtronic Vascular, INC. | $15.15 | 2020 | |
| Regeneron Healthcare Solutions, INC. | $11.36 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Yang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.